Navigation Links
Kendle to Present at the Wachovia 2008 Healthcare Conference
Date:1/28/2008

CINCINNATI, Jan. 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that Chairman and Chief Executive Officer Candace Kendle, PharmD will participate in the Wachovia 2008 Healthcare Conference. The conference will be held at the Langham Hotel in Boston, Jan. 29-31, 2008. Kendle's presentation is scheduled for Wednesday, Jan. 30 at 1:30 p.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events section) or at http://www.wsw.com/webcast/wa48/kndl. An archived version can be accessed following Kendle's presentation and will be available through Feb. 28. Slides accompanying the presentation will be available by 9 a.m. Eastern Time on Jan. 30 at http://www.kendle.com in the Investor Relations section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
2. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
3. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
4. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
7. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
8. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
9. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
10. Phytomedics Inc. to Present at Wachovia 2008 Healthcare Conference
11. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA ... dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at ... of the trial was to determine the safety, antitumor activity, and recommended phase ...
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, Inc. ... a Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based ... “The System Integrator Partner certification gives customers confidence that our engineers are fully ...
(Date:12/7/2016)... 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a ... of immunotherapeutic products for the treatment of cancer, ... Antibody Manufacturing Development Program with Cytovance Biologics ( ... its oregovomab antibody product. Supported by recent positive ... study in ovarian cancer patients, OncoQuest has engaged ...
Breaking Biology Technology:
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
(Date:11/29/2016)... , Nov. 29, 2016   ... identification and object recognition technologies, today released ... for fingerprint recognition solutions that run on ... fingerprint template using less than 128KB of ... compact devices that have limited on-board resources, ...
(Date:11/22/2016)... -- According to the new market research report "Biometric System ... Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and ... expected to grow from USD 10.74 Billion in 2015 to reach USD ... 2022. Continue Reading ... ...
Breaking Biology News(10 mins):